| Hospice By The Bay 17 East Sir Francis Drake Blvd, Larkspur, CA, 94939 | |
| (415) 927-2273 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| Name | Hospice By The Bay |
|---|---|
| Location | 17 East Sir Francis Drake Blvd, Larkspur, California |
| Hospice ID | 051508 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 310 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| NPI Number | 1255381547 |
| Organization Name | Hospice By The Bay |
| Address | 17 E Sir Francis Drake Blvd Larkspur, California, 94939 |
| Phone Number | (415)927-2273 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.2 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.3 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 90.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 95.1 | 93.3 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| Home Health Aides | 34 |
| Counselors | 7 |
| Licensed Practical or Vocational Nurses | 10.15 |
| Medical Social Workers | 21.5 |
| Physicians | 4.5 |
| Registered Nurses | 70.9 |
| Other Personnel | 82 |
| Total Employees | 230.05 |
|---|
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| Others | 6 |
| Total Volunteers | 6 |
|---|
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
In the past few years, researchers at the University of Helsinki have made several breakthroughs in discovering how the brain of preterm babies work, in developing treatments to protect the brain, and in developing research methods suitable for hospital use.
› Verified 6 days ago
| Hospice By The Bay Location: 17 East Sir Francis Drake Blvd, Larkspur, California, 94939 Phone: (415) 927-2273 |